182 related articles for article (PubMed ID: 17125255)
1. Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue.
Winum JY; Temperini C; El Cheikh K; Innocenti A; Vullo D; Ciattini S; Montero JL; Scozzafava A; Supuran CT
J Med Chem; 2006 Nov; 49(24):7024-31. PubMed ID: 17125255
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform.
Maryanoff BE; McComsey DF; Costanzo MJ; Hochman C; Smith-Swintosky V; Shank RP
J Med Chem; 2005 Mar; 48(6):1941-7. PubMed ID: 15771438
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.
De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors.
Temperini C; Winum JY; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 May; 17(10):2795-801. PubMed ID: 17346964
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX.
De Simone G; Vitale RM; Di Fiore A; Pedone C; Scozzafava A; Montero JL; Winum JY; Supuran CT
J Med Chem; 2006 Sep; 49(18):5544-51. PubMed ID: 16942027
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference.
Temperini C; Cecchi A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2009 Feb; 17(3):1214-21. PubMed ID: 19119014
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.
Casini A; Antel J; Abbate F; Scozzafava A; David S; Waldeck H; Schäfer S; Supuran CT
Bioorg Med Chem Lett; 2003 Mar; 13(5):841-5. PubMed ID: 12617904
[TBL] [Abstract][Full Text] [Related]
8. Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: role of hydrogen-bonding networks in ligand binding and drug design.
Abbate F; Supuran CT; Scozzafava A; Orioli P; Stubbs MT; Klebe G
J Med Chem; 2002 Aug; 45(17):3583-7. PubMed ID: 12166931
[TBL] [Abstract][Full Text] [Related]
9. Sulfamide derivatives with selective carbonic anhydrase VII inhibitory action.
Villalba ML; Palestro P; Ceruso M; Gonzalez Funes JL; Talevi A; Bruno Blanch L; Supuran CT; Gavernet L
Bioorg Med Chem; 2016 Feb; 24(4):894-901. PubMed ID: 26795114
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties.
Di Fiore A; Scozzafava A; Winum JY; Montero JL; Pedone C; Supuran CT; De Simone G
Bioorg Med Chem Lett; 2007 Mar; 17(6):1726-31. PubMed ID: 17251017
[TBL] [Abstract][Full Text] [Related]
12. Inhibition pattern of sulfamide-related compounds in binding to carbonic anhydrase isoforms I, II, VII, XII and XIV.
Gavernet L; Gonzalez Funes JL; Palestro PH; Bruno Blanch LE; Estiu GL; Maresca A; Barrios I; Supuran CT
Bioorg Med Chem; 2013 Mar; 21(6):1410-8. PubMed ID: 23266178
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors.
Di Fiore A; Pedone C; Antel J; Waldeck H; Witte A; Wurl M; Scozzafava A; Supuran CT; De Simone G
Bioorg Med Chem Lett; 2008 Apr; 18(8):2669-74. PubMed ID: 18359629
[TBL] [Abstract][Full Text] [Related]
14. Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups.
D'Ambrosio K; Smaine FZ; Carta F; De Simone G; Winum JY; Supuran CT
J Med Chem; 2012 Aug; 55(15):6776-83. PubMed ID: 22775345
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
Bioorg Med Chem Lett; 2005 Sep; 15(17):3828-33. PubMed ID: 16039848
[TBL] [Abstract][Full Text] [Related]
16. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2007 Apr; 50(7):1651-7. PubMed ID: 17343373
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.
Masereel B; Rolin S; Abbate F; Scozzafava A; Supuran CT
J Med Chem; 2002 Jan; 45(2):312-20. PubMed ID: 11784136
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase-II inhibition. what are the true enzyme-inhibitory properties of the sulfamide cognate of topiramate?
Maryanoff BE; McComsey DF; Lee J; Smith-Swintosky VL; Wang Y; Minor LK; Todd MJ
J Med Chem; 2008 Apr; 51(8):2518-21. PubMed ID: 18363349
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives.
Maryanoff BE; Costanzo MJ; Nortey SO; Greco MN; Shank RP; Schupsky JJ; Ortegon MP; Vaught JL
J Med Chem; 1998 Apr; 41(8):1315-43. PubMed ID: 9548821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
